// App-Quantinova.ai

: Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor

Researchers

Presenter

  • Toby Maher

Principal Investigators

  • Joanna Porter

  • Robert Chan

  • Rhena Eames

  • Yi Cui

  • Sarah Siederer

  • Simon Parry

  • Julia Kenny

  • Robert Slack

  • Richard Marshall

  • Jagdeep Sahota

  • Gaia Rizzo

  • Graham Searle

  • Frederick Wilson

  • Azeem Saleem

  • Arthur KangOmbe

  • David Fairman

  • William Fahy

  • Mitra Vahdati-Bolouri

Medical Centers

  • NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom

  • GlaxoSmithKline Research & Development Ltd, Stevenage, United Kingdom

  • Centre for ILD UCLH and Centre for Inflammation and Tissue Repair UCL, London, United Kingdom

  • Galecto Biotech, London, United Kingdom

  • Phastar, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • I

Study Id's

  • NCT03069989

  • NCT02052297

  • NCT02612051

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved